bioRxiv Science⌕ Search

Biology subjects

Quillard, T.

Publications and source records attributed to Quillard, T..

2 recordsLinked to original sources

ANGPTL6 variant induces cerebral vascular dysfunction and predisposes to intracranial aneurysm in mice

BackgroundIntracranial aneurysm (IA) is a common cerebrovascular abnormality characterized by localized dilation and wall thinning in intracranial arteries, that frequently leads to fatal sub-arachnoid hemorrhage. Pathophysiological mechanisms responsible for AI remains largely unknown, but increasing evidence suggest that genetic susceptibility plays a predominant role. We recently identified a rare nonsense variant in ANGPTL6 gene that prevented angiopoietin-like 6 (ANGPTL6) secretion and predisposed to IA. The aim of this study is now to understand why the ANGPTL6 variant predisposes to IA. MethodsAngptl6-knock in mice were generated by homologous recombination. Cerebral arteries of the circle of Willis have been analyzed under basal and hemodynamic overload conditions. Functional properties of cerebral arteries have been analyzed by pressure arteriography. Effect of recombinant ANGPTL6 have been assessed on vascular smooth muscle cells and ANGPTL6 partners have been analyzed by surface plasmon resonance. ResultsAngptl6-knock in mice display endothelial dysfunction expressed by reduced NO production in response to flow in cerebral arteries. They present exaggerated dilatation of cerebral arteries under hypertensive stress, and aggravated wall damage and aneurysmal remodeling of the intima and media at arterial bifurcations of the circle of Willis under hemodynamic overload. Matrix bound ANGPTL6 decreased VSMC migration and increased adhesion and FAK signaling activation, without affecting VSMC phenotype. Surface plasmon resonance analyses identified v{beta}5 integrin as a new ANPTL6 receptor. ConclusionsAngptl6-knock in mice mimicked the main features of IA in humans. ANGPTL6 appears to be an extracellular matrix component regulating vascular cell function, which may be involved in mechanosensing and generating adapted vascular cell responses to hemodynamic stress. Non-secreted ANGPTL6 variants would result in the loss of this function, thus favoring IA under conditions of hemodynamic overload.

physiology↗

Identification of miR136, miR155, and miR183 in vascular calcification in human peripheral arteries

ObjectiveVascular calcification (VC) is an independent risk factor for all-cause and cardiovascular mortality. This process contributes to atherosclerotic plaque disruption and thrombosis when close to the lumen, arterial stiffness, and limits endovascular treatment success. Vascular smooth muscle cells (VSMC) in the arterial wall play a major role in VC as they can acquire mineralizing properties when exposed to osteogenic conditions. Despite its clinical impact, there are still no dedicated therapeutic strategies targeting VC. DesignTo address this question, we used human calcified and none-calcified atherosclerotic arteries (ECLAGEN Biocollection) to screen and identify microRNA (miRs) associated with vascular calcification. MethodsWe combined non-biased miRNomic (microfluidic arrays) and transcriptomic analysis to select miR candidates and their putative target genes, with expression associated with vascular calcification and ossification. We further validated miR functional regulation and function on cell mineralization using primary human vascular SMC. ResultsOur study identified 12 miRs associated with vascular calcification in carotid and femoral arteries. Among those, we showed that miR136, miR155, and miR183 expression were regulated during VSMC mineralization and overexpression of these miRs was sufficient to promote smooth muscle cell mineralization. Cross-analysis of this miRNomic and a transcriptomic analysis led to the identification of CD73 and Smad3 pathways as putative target genes responsible for mediating miR155 pro-mineralizing function. ConclusionThese results highlight the potential benefit of miR155 inhibition in limiting VC development in peripheral atherosclerotic arteries. What this paper addsVascular calcification (VC) is an independent risk factor for all-cause and cardiovascular mortality. No pharmacological treatment is currently available. Our work using human healthy and atherosclerotic peripheral arteries allowed us to non-biasedly identify miR136, miR155, and miR183 as putative players in VC, as they associate with calcification in human atherosclerotic lesions, and are sufficient to induce vascular cell mineralization in vitro. Among those, miR155 appeared the most important driver of osteogenesis in vitro, making it a candidate for targeting VC in patients.

molecular biology↗